Healthia Crescita futura

Future criteri di controllo 4/6

Healthia is forecast to grow earnings and revenue by 40.3% and 8.2% per annum respectively.

Informazioni chiave

40.3%

Tasso di crescita degli utili

n/a

Tasso di crescita dell'EPS

Healthcare crescita degli utili	23.1%
Tasso di crescita dei ricavi	8.2%
Rendimento futuro del capitale proprio	n/a
Copertura analitica	Low
Ultimo aggiornamento	13 Sep 2023

Aggiornamenti recenti sulla crescita futura

Recent updates

Previsioni di crescita degli utili e dei ricavi

DB:HE3 - Stime future degli analisti e dati finanziari passati (AUD Millions )
Data	Ricavi	Guadagni	Flusso di cassa libero	Liquidità dell'operazione	Avg. Numero di analisti
6/30/2025	298	15	25	43	1
6/30/2024	280	14	26	45	1
6/30/2023	253	5	15	23	N/A
3/31/2023	242	3	14	20	N/A
12/31/2022	232	1	12	18	N/A
9/30/2022	216	-1	13	18	N/A
6/30/2022	200	-3	14	17	N/A
3/31/2022	184	-2	13	16	N/A
12/31/2021	168	0	12	15	N/A
9/30/2021	152	3	18	21	N/A
6/30/2021	137	5	23	26	N/A
3/31/2021	121	6	26	28	N/A
12/31/2020	105	7	29	31	N/A
9/30/2020	96	5	22	24	N/A
6/30/2020	87	3	16	17	N/A
3/31/2020	83	1	9	10	N/A
12/31/2019	79	0	2	3	N/A
9/30/2019	72	0	-1	1	N/A
6/30/2019	65	-1	-4	-2	N/A
3/31/2019	57	-2	-3	0	N/A
12/31/2018	48	-3	-1	2	N/A
9/30/2018	41	-2	-1	1	N/A
6/30/2018	34	-2	0	1	N/A
6/30/2017	67	4	N/A	N/A	N/A
6/30/2016	67	4	N/A	N/A	N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: HE3's forecast earnings growth (40.3% per year) is above the savings rate (0.5%).

Guadagni vs Mercato: HE3's earnings (40.3% per year) are forecast to grow faster than the German market (14.7% per year).

Guadagni ad alta crescita: HE3's earnings are expected to grow significantly over the next 3 years.

Ricavi vs Mercato: HE3's revenue (8.2% per year) is forecast to grow faster than the German market (4.6% per year).

Ricavi ad alta crescita: HE3's revenue (8.2% per year) is forecast to grow slower than 20% per year.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Insufficient data to determine if HE3's Return on Equity is forecast to be high in 3 years time

Healthia Crescita futura

Future criteri di controllo 4/6

Informazioni chiave

Aggiornamenti recenti sulla crescita futura

Healthia Limited Provides Financial Guidance for the Year Ending June 30, 2022

Recent updates

Healthia Limited Announces Board Changes

Pacific Equity Partners made an offer to acquire Healthia Limited from MA Financial Group Limited (ASX:MAF), Wilson Asset Management (International) Pty Ltd. and Regal Partners Limited (ASX:RPL) for an offer per share of AUD 1.8.

New major risk - Financial position

Harold Bidco Pty Ltd made an offer to acquire Healthia Limited for an offer per share of AUD 1.8.

Harold Bidco Pty Ltd made an offer to acquire Healthia Limited for an offer per share of AUD 1.8.

Full year 2023 earnings released: EPS: AU$0.046 (vs AU$0.028 loss in FY 2022)

Healthia Limited to Report Fiscal Year 2023 Results on Aug 31, 2023

New minor risk - Market cap size

First half 2023 earnings released: EPS: AU$0.03 (vs AU$0.001 loss in 1H 2022)

Healthia Limited (ASX:HLA) agreed to acquire Kosmac & Clemens Optometrists.

Healthia Limited Appoints Damien Peters as Group Chief Financial Officer

Healthia Announces Resignation of Chris Banks as CFO

Independent Non-Executive Director recently bought €54k worth of stock

Healthia Limited (ASX:HLA) completed the acquisition of Corio Bay Health Group.

Less than half of directors are independent

Healthia Limited (ASX:HLA) acquired Watsonia Physiotherapy.

Healthia Limited, Annual General Meeting, Nov 23, 2022

Healthia Limited (ASX:HLA) entered into binding agreement to acquire Corio Bay Health Group.

Full year 2022 earnings released: AU$0.028 loss per share (vs AU$0.065 profit in FY 2021)

Healthia Limited Determines Not to Declare the Payment of A Final Dividend for 2022

Healthia Limited to Report Fiscal Year 2022 Results on Aug 31, 2022

Healthia Limited Provides Financial Guidance for the Year Ending June 30, 2022

Less than half of directors are independent

Healthia Limited Announces Board Changes

Now 20% undervalued

First half 2022 earnings: EPS in line with expectations, revenues disappoint

Healthia Limited Announces Dividend on HLA - ORDINARY FULLY PAID for the Six Months Ended 31 Dec. 2021, Payable on 24 March 2022

Healthia Limited Recommends Interim Dividend, Payable on March 22, 2022

Healthia Limited to Report First Half, 2022 Results on Feb 28, 2022

Healthia Limited (ASX:HLA) entered into binding agreement to acquire Mornington Peninsula Family Physiotherapy.

Less than half of directors are independent

Previsioni di crescita degli utili e dei ricavi

Previsioni di crescita futura degli analisti

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

Scoprire le aziende in crescita